Launchpad Therapeutics develops novel therapeutics for next-generation anti-cancer treatments, focusing on brain tumor therapies with the aim of improving clinical and treatment outcomes.
investor of
Metrics
marketPRIVATE
msh_idCOM:LAUNCHPADTHERAPEUTICS
localeus
websitehttps://launchpadtherapeutics.com
source_ref22319159-f53a-4ca4-a471-1552bd56cf92
products_or_servicesDevelopment of novel anti-cancer therapeutics, particularly for brain tumors, including drug design, development, and pre-market assessment.
United States